Enrichment analysis revealed that COAD patients with high ATOH1 expression showed significant upregulation in their humoral immunity, as well as other related pathways, but were significantly downregulated in pathways such as Notch and WNT. This evidence concerns the gene ATOH1 and colon adenocarcinoma.